[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343277-105":59,"doc-detail-343277-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","risk-of-gastric-and-small-intestinal-cancer-in-patients-with-lynch-syndrome-data-from-a-large-community-based-us-population","Risk of Gastric and Small Intestinal Cancer in Patients With Lynch Syndrome - Data From a Large, Community-Based US Population","","Risk of gastric and small intestinal cancer in Lynch syndrome (LS) remains insufficiently characterized. A retrospective cohort at Kaiser Permanente Northern California identified all LS patients diagnosed between January 1, 1997 and December 31, 2020. Cumulative incidence for gastric and small intestinal cancer was calculated with competing-risk methodology. Among 1,106 patients with a median 19.3-year follow-up, 11 developed gastric cancer and 11 developed small intestinal cancer. Highest risk was seen in MSH2 and MLH1 pathogenic variant carriers; Helicobacter pylori infection increased gastric cancer risk. The findings support considering H. pylori testing and treatment for LS patients.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/risk-of-gastric-and-small-intestinal-cancer-in-patients-with-lynch-syndrome-data-from-a-large-community-based-us-population/343277/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/risk-of-gastric-and-small-intestinal-cancer-in-patients-with-lynch-syndrome-data-from-a-large-community-based-us-population/343277.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was the risk of gastric and small intestinal cancer estimated in Lynch syndrome patients?","Question",{"text":112,"@type":113},"The study used a retrospective cohort and calculated cumulative incidence for gastric and small intestinal cancer with a competing-risk methodology.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What was the overall follow-up and how many patients developed each cancer type?",{"text":117,"@type":113},"Among 1,106 LS patients with a median follow-up of 19.3 years, 11 developed gastric cancer and 11 developed small intestinal cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"Which genetic variant carriers and clinical factor were linked to higher cancer risk?",{"text":121,"@type":113},"Pathogenic variant carriers of MSH2 and MLH1 had the highest risk, and history of Helicobacter pylori infection was associated with increased gastric cancer risk.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343277,1790156138,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","ARTICLE 1  \n\n| INTRODUCTION: Risk of gastric and small intestinal cancer in Lynch syndrome (LS) remains poorly understood. We investigated the risk of gastric and small intestinal cancer in patients with LS in a large, communitybased population.\u003Cbr>METHODS: This retrospective cohort study included all patients diagnosed with LS between January 1, 1997, and December31,2020, at Kaiser Permanente Northern California. Cumulative incidence of gastric cancer and small intestinal cancer was calculated using competing risk methodology.\u003Cbr>RESULTS: Among 1,106 patients with LS with a median follow-up of 19.3 years (interquartile range [IQR] 9.4–24.0years),11developed gastric cancer(8 MSH2,2 MLH1 and1 PMS2)with a median diagnosis age of 56 years (IQR 42–63 years) and 11 developed small intestinal cancer (6 MSH2, 3 MLH1 , 1 MSH6 and 1 PMS2) with a median diagnosis age of 57 years (IQR 50–66 years) . Cumulative incidence by age 80 years was 7.26%(95% confidence internal [CI], 1.80–18.03%) for men and 3.43%(95% CI, 0.50–11.71%) for women for gastric cancer and 7.28%(95% CI, 3.19–13.63%) for men and 2.21%(95% CI, 0.23–9.19%) for women for small intestinal cancer. Pathogenic variant carriers of MSH2 and MLH1 had the highest risk of gastric and small intestinal cancer. History of Helicobacter pylori infection was associated with increased risk of gastric cancer (adjusted odds ratio 5.52; 95% CI, 1.72–17.75) .\u003Cbr>DISCUSSION: Patients with LS, particularly MSH2and MLH1 pathogenic variant carriers, had significantly increased lifetime risk of gastric and small intestinal cancer. Testing and treatment of H. pyloriinfection should be considered for all patients with LS.\u003Cbr>KEYWORDS: Lynch syndrome; gastric cancer; small intestinal cancer; risk assessment\u003Cbr>SUPPLEMENTARY MATERIAL accompanies this paper at [http://links.lww.com/CTG/B162](http://links.lww.com/CTG/B162) |  |\n| --- | --- |\n| Clinical and Translational Gastroenterology 2024;15:e00739. [https://doi.org/10.14309/ctg.0000000000000739](https://doi.org/10.14309/ctg.0000000000000739) |  |\n| INTRODUCTION\u003Cbr>Lynch syndrome (LS) is the most common inherited colorectal cancer syndrome (1) . It is caused by pathogenic variants (PVs) in mismatch repair (MMR) genes (MLH1, MSH2, MSH6, PMS2, and EPCAM) involved in the human DNA repair machinery (2) . Although numerous studies have reported the beneﬁts of intensive screening and surveillance colonoscopy in reducing colorectal cancer-related mortality in patients with LS (3), the beneﬁts of screening for gastric cancer and small intestinal cancer in patients with LS are much less clear. | Limited data to date suggest that the cumulative incidence of gastric cancer and small intestinal cancer by age80years inMLH1 PV carriers is 5%–7% and 0.4%–11%, respectively; in MSH2 PV carriers, the cumulative incidence is 0.2%–9.0% for gastric cancer and 1 . 1%–10% for small intestinal cancer, with less available information for MSH6 and PMS2 PV carriers (4–6) . Because of paucity of good quality evidence, professional society guidelines on endoscopic screening for gastric cancer and small intestinal cancer among patients with LS vary widely (4,7–9) . For example, the most recent 2023 National Comprehensive Cancer Network |\n\nRisk of Gastric and Small Intestinal Cancer in Patients With Lynch Syndrome: Data From a Large, Community-Based US Population  \nChristina F. Lin, MD1 , *, Holly E. Carwana, MS, CGC2 , *, Sheng-Fang Jiang, MS3 and Dan Li, MD3 ,4  \nSTOMACH  \n1Department of Internal Medicine, Kaiser Permanente Northern California, Santa Clara, California, USA; 2Department of Genetics, Kaiser Permanente Northern California, Oakland, California, USA; 3Division of Research, Kaiser Permanente Northern California, Oakland, California, USA; 4Department of Gastroenterology, Kaiser Permanente Northern California, Santa Clara, California, USA. Correspondence: Dan Li, MD. E-mail: [Dan.X.Li@kp.org](Dan.X.Li@kp.org).  \n*Christina F. Lin and Holly E. Carwana contributed equally","cbCaiaHzS4TlXIU8","https://ap.wps.com/l/cbCaiaHzS4TlXIU8","pdf",118125,"English","# Introduction\n# Methods\n## Setting\n## Study design and data ascertainment\n# Results\n# Discussion","[{\"question\":\"How was the risk of gastric and small intestinal cancer estimated in Lynch syndrome patients?\",\"answer\":\"The study used a retrospective cohort and calculated cumulative incidence for gastric and small intestinal cancer with a competing-risk methodology.\"},{\"question\":\"What was the overall follow-up and how many patients developed each cancer type?\",\"answer\":\"Among 1,106 LS patients with a median follow-up of 19.3 years, 11 developed gastric cancer and 11 developed small intestinal cancer.\"},{\"question\":\"Which genetic variant carriers and clinical factor were linked to higher cancer risk?\",\"answer\":\"Pathogenic variant carriers of MSH2 and MLH1 had the highest risk, and history of Helicobacter pylori infection was associated with increased gastric cancer risk.\"}]","Risk of Gastric and Small Intestinal Cancer in Patients With Lynch Syndrome - Data From a Large, Community-Based US Population | PDF",1790050543,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ffa9dfba21ca13211b3f5acd322730ef.webp",983,1296,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b542df4e859ba08172bbcc549cfe834.webp",982,1294,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f17985b44a7c72abca4b4d08663677c.webp",981,1293,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e9def23bdf8d4ec416451d1b746ea40b.webp",980,1292]